LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
 87.86 84.90 430 7680 0.0560 0.2835
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 87.86 84.90 6962 7680 0.9065 0.9700
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 87.86 84.90 601 7680 0.0783 0.3514
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 87.86 84.90 7647 7680 0.9957 0.9987
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 89.57 84.90 453 7494 0.0604 0.2957
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 89.57 84.90 7238 7494 0.9658 0.9893
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 89.57 84.90 521 7494 0.0695 0.3240
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 89.57 84.90 7885 7494 1.0521 1.0158
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 91.27 84.90 474 7420 0.0639 0.3056
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 91.27 84.90 7433 7420 1.0017 1.0005
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 91.27 84.90 489 7420 0.0659 0.3119
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 91.27 84.90 8108 7420 1.0927 1.0277
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 92.98 84.90 467 7257 0.0643 0.3043
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 92.98 84.90 7655 7257 1.0548 1.0167
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 92.98 84.90 489 7257 0.0674 0.3137
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 92.98 84.90 8324 7257 1.1469 1.0432
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 94.68 84.90 400 7000 0.0571 0.2757
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 94.68 84.90 7906 7000 1.1294 1.0386
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 94.68 84.90 353 7000 0.0504 0.2509
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 94.68 84.90 8546 7000 1.2208 1.0637
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.0016667
 2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 2.66 84.90 616 285 2.1558 2.1015
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
 2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 2.66 84.90 707 285 2.4743 2.3554
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
 4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
K14